Brief: Somnomed Keeps FY24 Guidance Unchanged
30/01/2024 01:00
Jan 30 (Reuters) - Somnomed Ltd SOM.AX :
* FY24 GUIDANCE REMAINS UNCHANGED
* Q2 FY24 REVENUE OF A$23.7 MILLION
Source text for Eikon: ID:nASX1NZwZ6
Further company coverage: SOM.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on SomnoMed
See all newsAustralia's Somnomed jumps most in 7 months on strong half-year earnings
Brief: Somnomed® Increases Investment In Managed Care Infrastructure
Australia's Somnomed hits 32-month high on upbeat revenue growth
Brief: Somnomed Says Q1 FY26 Revenue Up 13.5% To A$28.7 Million
Brief: Somnomed Says FY EBITDA AUD 9.2 Million